Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CMT-dos > Interstitial lung disease > Flashcards

Interstitial lung disease Flashcards

1
Q

Interstitial Lung Diseases (ILD)

general

A

Collection of disorders that involves inflammation and scarring (fibrosis) of the lung interstitium (the space between the capillaryendotheliumand the alveolarepithelium
The lung becomes “stiff” (reduced distensibility) and compromises lung expansion

Causes
Idiopathic or secondary to connective tissue diseases, medications, malignancies, occupational exposure, or allergens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ILD

pattern on spirometry

A

Restrictive pattern on spirometry
Normal FEV1/FVC ratio (> 0.70) and a reduction in TLC below 80% of the predicted value
Decreased diffusion capacity for carbon monoxide (DLCO)
Impaired gasdiffusionacross the alveolar membrane:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Idiopathic pulmonaryfibrosis (IPF)

general and RF

A

Characterized by chronic, progressive, irreversiblefibrosis (“scar tissue”) of the lung parenchyma

Epidemiology:
Estimatedprevalencein the United States: 10–60 per 100,000
Occurs primarily in elderly individuals
Commonly diagnosed in the 50-60 years old
Men > Women

Risk factors: male, advanced age, history of tobacco use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Idiopathic pulmonaryfibrosis

patho

The mechanism triggering IPF is poorly understood

A

Environmental exposure and possible genetic predisposition

Recurrent alveolar epithelial damage → type I pneumocytes release transforming growth factor beta1 → proliferation of type II pneumocytes → stimulate fibroblasts that are found in the interstitial tissue
Activated fibroblastsdevelop into myofibroblast (fibroblasts with smooth muscle cell properties)

Myofibroblast secrete:
Reticular fibers - a type of collagen which provides structural strength
Elastic fibers - provide the rubber-band like elasticity of the lungs

Failure of normal myofibroblastapoptosis→ accumulation of collagen leads to thickening of the interstitial layer

Consequences:
Restrictive lung - poor air in and out of the lung
↓gas exchange

Fundamental problem….too many myofibroblasts and too much collagen!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Idiopathic pulmonaryfibrosis

clin man

A

progressive disease

Asymptomatic early in the disease process
Moderate to advanced stage:
Chronic dyspnea-Initially exertional, Progressive, eventually occurring at rest
Chronic nonproductive cough
Reduced exercisetolerance
Chest pain

Associated systemic symptoms (uncommon):
Fatigue
Low-grade fever
Weight loss
Myalgias

will lead to r sided heart failure and pulm HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Idiopathic pulmonaryfibrosis

PE findings
Auscultation
secondary disease sx

A

Bibasilar fine inspiratory (“Velcro-like”) crackles on auscultation
End-inspiratory “squeaks” in advanced disease withbronchiectasis
Digitalclubbing
Cyanosis

Patients can present withpulmonary hypertension (PH) andcor pulmonale:
Pitting edema (pedal or sacral)
Jugular venous distention
Cyanosis
Split second heart sound
(this is later as disease progresses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Idiopathic pulmonaryfibrosis

Hx Dx
Med use

A

Diagnosed by a combination of radiologic, pathologic, and clinical investigations
Critical to obtain a complete patient history
Occupational history
Recreational history
Environmental history
Radiationexposure

Notable medications associated with pulmonary fibrosis:
Amiodarone
Bleomycin
Nitrofurantoin
Methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Idiopathic pulmonaryfibrosis –

Diagnosis Spirometry

A

Pulmonary function test
Reveals ↓ lung volumes (restrictive pattern):
Vital capacity
Total lung capacity(TLC)
Forcedvital capacity(FVC)
Forced expiratory volume in 1 sec
FEV1/FVC ratio is greater than 80% (increased) due to a significant decrease in forced vital capacity (FVC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Idiopathic pulmonaryfibrosis

imaging

A

Chestx-ray
May look normal in early disease
Reticulonodular infiltrates
Bilateral, basal, and symmetrical

High-resolution CT scan
Significantly more sensitive and specific
Features (predominantly seen in the lower lobes):
Peripheral and subpleural reticular septal thickening
Tractionbronchiectasis
Honeycombing
Lung architecturaldistortion
Superimposed ground-glass opacities may be seen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Idiopathic pulmonaryfibrosis

biopsy and labs

A

Lung biopsy- best for Dx
Surgical specimens can be obtained using video-assisted thoracoscopic surgery (VATS)
Supporting laboratory evaluation to exclude other causes ofILD and guide management:

Erythrocyte sedimentation rateand CRP
Antinuclearantibodies
Rheumatoid factorand anti–cyclic citrullinated peptideantibodies
Aldolaseand CK
Myositis-specificantibodies
Anti-SSA/Ro and anti-SSB/Laantibodies
Serum ACE level

pulmonologist would do this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Idiopathic pulmonaryfibrosis

lifestyle mods

A

Smoking cessation
Vaccinations: influenza, Covid-19, and pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Idiopathic pulmonaryfibrosis

Tx

A

Antifibrotic drugs
Approved for delaying progression
Do not significantly improvemortality

Oxygen therapy
Indicated when the patient’sresting or ambulatory oxygen saturation are < 88%

Lung transplant
Only definitive treatment
Bilaterallung transplantationis more commonly used than singlelung transplantation
Early referral should be considered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sarcoidosis

general

A

Multisystem inflammatory disease characterized by the formation ofnoncaseating granulomas that are most likely caused by a cell-mediated immune reaction
Etiology is undetermined but is most likely multifactorial
more common in african american women
Potential triggering exposure: environmental exposure or infectious agent
Genetic predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

sarcoidosis

pulmonary or extrapulmonary

A

Pulmonary sarcoidosisis a restrictive interstitial lung disease with granuloma formation in the:
Lungs(90% ofpatients)
Thoraciclymph nodes(hilar and mediastinal)

Extrapulmonary sarcoidosisis characterized by granuloma formation in:
Eyes – uveitis
Skin – erythema nodosum; macular or papular lesions
Joints
Heart – arrhythmias
Kidney
CNS andperipheral nervous system
Exocrine glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

sarcoidosis

Patho

A

Phagocytosisof a newantigenbyantigen-presenting cells (macrophagesanddendritic cells)
Activated macrophages present the antigento helper T cellsvia the HLA-CD4 complex
Activated T cellsandmacrophagesrelease inflammatory mediators (Th1response):
Interleukin 2 (IL-2)
Interferon gamma
Tumornecrosisfactor (TNF)
Othercytokinesandchemokines
Inflammatory mediators causemacrophagesto fuse into multinucleatedgiant cells
Unable to destroy the antigens, the multinucleatedgiant cellswall them off →noncaseating granulomaformation
Fibroblasts are recruited and surround granulomas and may progress tofibrosis

NON CASEATING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sarcoidosis

CLin man

A

Initially progresses slowly, with few symptoms
Symptoms appear as an increasing number of granulomas affecting organ function
Cutaneous sarcoidosisis known as one of the “great imitators”\

17
Q

Sarcoidiosis

imaging

A

Chestx-ray
Bilateral hilarlymphadenopathy(classic finding)
Bilateral reticulonodular infiltrates (often upper lobes)
Honeycombing (end-stage disease)- not for exam though
Chest CT scan
Bilateral hilar and mediastinallymphadenopathy
Small centrilobular parenchymal nodules
Ground-glass opacification

18
Q

sarcoidosis

BAL

A

Bronchoalveolar lavage (BAL)
Obtained primarily to exclude alternative diagnosis
Lymphocytosis (T-cells)≥ 25% suggests a granulomatous process

19
Q

sarcoidosis

labs

A

Labs
Elevated ACE level
Measure of the level of angiotensin-convertingenzyme in the blood
Elevated due to additional production by activated macrophages and epithelioid cells in the granulomas

20
Q

sarcoidosis

biopsy

A

Gold standard for diagnosis
Obtained from the most accessible affected site (skinlesions)
Lung biopsies can be obtained via bronchoscopyor surgically
Key finding: well-definednoncaseating granulomas
Noncaseating: no centralnecrosis
Multinucleatedgiant cells

21
Q

sarcoidosis

Tx

A

Minimal symptoms → observation
Most symptoms resolve spontaneously within a few weeks
Complete remission from sarcoidosis typically happens within a few years
Moderate-severe symptoms
Corticosteroids: first-line therapy
Steroid-sparing agents:second-line therapy:
Azathioprine
Methotrexate
Lung transplantation:in cases of advanced pulmonaryfibrosis

22
Q

Pneumoconiosis

A

Pneumoconiosis is an occupational disease that results from the inhalation and deposition of mineral dusts and other inorganic particles in the lung; categorized according to the type of causative particle involved or by the type of response provoked
Asbestosis
Silicosis
Coal Worker’s Pneumoconiosis

Exposure has greatly decreased due to the enforcement of environmental rules and regulations

23
Q

Pneumoconiosis

patho

A

Inhaled toxic fibers/dust cannot be metabolized by the body and accumulate in the alveolar ducts
Particles ofappropriate sizeto be retained in lung (1-5μm)
The fibers are engulfed bymacrophages, which undergo lysis and releasecytokines
Cytokines induce an inflammatory reaction, producingairway obstruction and stimulatingfibroblasts
Fibroticscarring leads to thickening of the airways, reducedelasticity, and impairedgas exchange

leading to restrictive pattern

24
Q

Pneumoconiosis

general S/Sx

A

Progressive exertionaldyspnea
Dry cough
May be productive in the morning, with clear-to-white sputum
Chest discomfort due to heart failure following pulmonary hypertension
Inspiratoryralesor crackles
Digitalclubbingin advanced disease

Persistent cough with sputum and wheezing is unusual, but may be present if there has been associated cigarette smoking

25
Q

pneumoconiosis

Dx

A

Documented exposure history to a known toxic agent
A typicallatent period between exposure and symptoms
Clinical and radiological features compatible with the known features of the disease
Exclusion of any other disease that could explain the findings

26
Q

pneumoconiosis

Tx

A

No definitive treatment for pneumoconiosis, regardless of the clinical stage
Immediate cessation of exposure is recommended
Cessation of tobaccosmoking

Management is largely supportive and focuses on the prevention of further progression and complications (oxygen is dyspnea)

Prophylacticvaccinationagainstinfluenza, COVID-19and pneumococcal pneumonia
Oxygen therapy is often necessary to relievedyspnea

Early systemic oral glucocorticoid therapy may relieve symptoms, improve lung appearance on imaging, and normalizepulmonary function testing scores

Lung transplantationhas been performed for advanced pneumoconiosis with respiratory failure, but evidence on patient outcomes is lacking- not endorsed

27
Q

Asbestosis

general

A

ILD caused by inhalation of asbestos fibers
Carcinogen
Known to cause mesothelioma, lung cancer (bronchogenic carcinoma), laryngeal cancer and ovarian cancer

Historically been used in construction, shipping, mining, and aerospace engineering commercial use because of their high electrical and thermal resistance and low cost

Dose-dependent disease
Most prevalent in disciplines where the intensity of exposure is high
Cigarette smoking accelerates disease progression
Onset after 10-20 years of exposure

28
Q

Asbestosis

Xray and CT

A

Chest x-ray
Diffuse irregular opacities with a fine reticular pattern
Calcified or noncalcifiedpleural plaques

Chest CT scan
Reticular opacities in the lower lung zones
Interlobular pleural thickening
Calcified or noncalcified pleural plaques
Bronchiectasis
Pleural effusion

29
Q

Asbestosis

BAL

A

Bronchoalveolar lavage (BAL)
Shows asbestosis bodies

dx depends on finding these

30
Q

asbestosis

A
31
Q

Silicosis

general

A

ILD caused by inhalation of crystalline silica dust
Most common form of occupational lung disease
Silica exposure
Mining, sandblasting, quarry, ceramics, and foundry workers; and in grinding, stone cutting, fiberglass, and glass manufacturing
Onset after > 10 years of exposure but can manifest after several months of intense daily exposure
Silica is known to weaken cell-mediated immunity
Increased susceptibility to infections, especially tuberculosis
When assessing patients for silicosis, screen for tuberculosis

32
Q

Silicosis

Dx

start w imaging then BAL

A

Chest x-ray
Multiple, small nodular opacities (1-10 mm) in the upper lung fields
Calcification of nodules
Chest CT scan
Calcification of the periphery of mediastinal and hilar lymph nodes (referred to as eggshell calcifications)
Pleural thickening

Bronchoalveolar lavage (BAL)
Silica-laden macrophages

33
Q

silicosis

A

“eggshell calcification”

34
Q

Coal Worker’s Pneumoconiosis

general

A

ILD caused by exposure to coal dust
Onset after > 10 years of exposure
Large amorphous black masses develop that occasionally have a liquified centers

35
Q

Anthracosis

general

A

Chronic, low level environmental exposure to coal dust or wood smoke
Black discoloration of the bronchial mucosa
Generally considered benign; can progress to anthracofibrosis (fibrotic changes and destruction of bronchial walls)

usually benign, milder col miners pneumoconiosis

36
Q

coal miners

Dx

imaging to BAL

A

Chest x-ray
Small (1-5 mm) round nodular opacities in the upper lung fields
Occasional appearance of reticular or reticulonodular opacities
Conglomerate masses in advances disease

Chest CT scan
Diffuse (typicallyperilymphatic) distribution of small nodules throughout the lungs, which tend to favor the upper lungs

Bronchoalveolar lavage (BAL)
Black pigmented macrophages

Silicosis and CWP are not easily distinguished from one another on imaging studies

37
Q
A

CMT-dos (95 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions